Home › Funds › TANG CAPITAL MANAGEMENT LLC › CORT
TANG CAPITAL MANAGEMENT LLC position in CORT
CORCEPT THERAPEUTICS INC · Health Care
TANG CAPITAL MANAGEMENT LLC reported holding 1,500,000 shares of CORT (CORCEPT THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$130.4M, representing 5.92% of its reported portfolio and ranking #6 among its reported holdings. TANG CAPITAL MANAGEMENT LLC has disclosed CORT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How TANG CAPITAL MANAGEMENT LLC's CORT position evolved
TANG CAPITAL MANAGEMENT LLC first disclosed a stake in CORT in Q4 2025 at 156,764 shares (US$5.5M). The position peaked in Q2 2026 at 1,500,000 shares, worth US$130.4M. Across 3 filings, TANG CAPITAL MANAGEMENT LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,500,000 shares valued at US$130.4M. Notable position changes include a 857% increase in Q1 2026 (shares rose 116% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 156.76K | $5.46M | New |
| Q1 2026 | 1.50M | $60.47M | Add |
| Q2 2026 | 1.50M | $130.43M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CORT and 13F data
CORT (CORCEPT THERAPEUTICS INC) is a Health Care company. 38 other funds we track also report a position in CORT — the largest reported positions include Renaissance Technologies (US$457.5M), Parallel Advisors, LLC (US$344.5M), MPM BioImpact LLC (US$67.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CORT
- Renaissance Technologies 5.26M sh · $457.50M · Q2 2026
- Parallel Advisors, LLC 3.96M sh · $344.51M · Q2 2026
- MPM BioImpact LLC 771.03K sh · $67.04M · Q2 2026
- EMERALD ADVISERS, LLC 748.33K sh · $65.07M · Q2 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 464.90K sh · $40.42M · Q2 2026
- PERCEPTIVE ADVISORS LLC 398.38K sh · $34.64M · Q2 2026
More on TANG CAPITAL MANAGEMENT LLC
FAQ
How long has TANG CAPITAL MANAGEMENT LLC held CORT?
TANG CAPITAL MANAGEMENT LLC has disclosed CORT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is TANG CAPITAL MANAGEMENT LLC's current position in CORT?
As of Q2 2026, TANG CAPITAL MANAGEMENT LLC holds 1.50M shares of CORT (CORCEPT THERAPEUTICS INC), valued at $130.43M, representing 5.92% of its reported portfolio and ranking #6.
Has TANG CAPITAL MANAGEMENT LLC been buying or selling CORT?
In the latest 13F filing (Q2 2026), TANG CAPITAL MANAGEMENT LLC held unchanged its position in CORT. The position peaked in Q2 2026 at 1.50M shares.
Which other funds hold CORT?
Other major institutional holders of CORT include Renaissance Technologies, Parallel Advisors, LLC, MPM BioImpact LLC, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.